- Home
- DAO vs PHAR Comparison
DAO vs PHAR Comparison
Compare DAO & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAO
- PHAR
- Stock Information
- Founded
- DAO 2006
- PHAR 1988
- Country
- DAO China
- PHAR Netherlands
- Employees
- DAO N/A
- PHAR N/A
- Industry
- DAO Other Consumer Services
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- DAO Real Estate
- PHAR Health Care
- Exchange
- DAO Nasdaq
- PHAR Nasdaq
- Market Cap
- DAO 1.1B
- PHAR 951.7M
- IPO Year
- DAO 2019
- PHAR N/A
- Fundamental
- Price
- DAO $9.44
- PHAR $17.07
- Analyst Decision
- DAO
- PHAR Strong Buy
- Analyst Count
- DAO 0
- PHAR 3
- Target Price
- DAO N/A
- PHAR $30.00
- AVG Volume (30 Days)
- DAO 133.7K
- PHAR 19.8K
- Earning Date
- DAO 11-20-2025
- PHAR 11-06-2025
- Dividend Yield
- DAO N/A
- PHAR N/A
- EPS Growth
- DAO 155.59
- PHAR N/A
- EPS
- DAO 0.17
- PHAR 0.00
- Revenue
- DAO $798,421,874.00
- PHAR $362,274,000.00
- Revenue This Year
- DAO $5.78
- PHAR $17.70
- Revenue Next Year
- DAO $13.12
- PHAR $12.25
- P/E Ratio
- DAO $57.46
- PHAR $3,068.84
- Revenue Growth
- DAO N/A
- PHAR 26.78
- 52 Week Low
- DAO $4.99
- PHAR $7.35
- 52 Week High
- DAO $11.82
- PHAR $17.76
- Technical
- Relative Strength Index (RSI)
- DAO 42.84
- PHAR 60.37
- Support Level
- DAO $8.70
- PHAR $15.81
- Resistance Level
- DAO $9.94
- PHAR $17.50
- Average True Range (ATR)
- DAO 0.69
- PHAR 0.91
- MACD
- DAO -0.11
- PHAR 0.09
- Stochastic Oscillator
- DAO 32.17
- PHAR 80.47
About DAO Youdao Inc. each representing one
Youdao Inc develops and markets software applications. It engages in developing technologies to provide learning content, applications, and solutions. The firm operates in three segments: Learning services, Smart devices, and Online marketing services. The majority of its revenue comes from the Learning services segment, which generates revenues from online courses, mainly including Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The learning products segment includes sales of smart devices such as the Youdao Dictionary Pen and the Youdao Pocket Translator. Geographically, all of its revenue is generated from the People's Republic of China.
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.